Oral COVID-19 Vaccine Candidates Found Effective with Hamsters

California-based Vaxart Inc. announced on October 14, 2020, the topline results from its Hamster Challenge Study showed 'hamsters that received (2) oral doses of the COVID-19 VXA-CoV2-1 vaccine candidate showed no systemic weight loss, a key indicator of protection against COVID-19 in this animal model.'